Clinical Trials on Bladder Mixed Adenocarcinoma
Total 13307 results
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
Rush University Medical CenterWithdrawnImmunotherapy | Cancer of Skin | Exercise, Aerobic | Cancer of Kidney | Cancer of BladderUnited States
-
Tianjin Medical University Cancer Institute and...Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsNot yet recruitingNeoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
-
Walter Reed National Military Medical CenterRecruitingOveractive Bladder SyndromeUnited States
-
Armed Forces Hospital, PakistanRecruitingProstatic Neoplasms | Bladder NeoplasmPakistan
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingUrolithiasis | Overactive Bladder SyndromeChina
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
University Hospital, GhentAstellas Pharma Inc; MedtronicCompleted
-
University Hospital, GhentTerminatedOveractive Bladder SyndromeBelgium
-
Stimvia s.r.o.CompletedOveractive Bladder (OAB) | Failed Any OAB PharmacotherapyCzechia
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Chung Shan Medical UniversityUnknownOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalCompletedOveractive Bladder SyndromeTaiwan
-
BioCis Pharma LtdTurku University Hospital; FinnMedi Oy; Tampere University HospitalCompletedCis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder CancerFinland
-
SalvatCompletedOveractive Bladder (OAB)
-
PfizerCompletedOveractive Bladder SyndromeUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid AdenocarcinomaUnited States, Canada
-
Northwestern UniversityNorthShore University HealthSystemCompletedKidney Cancer | Prostate Cancer | Bladder CancerUnited States
-
Hospital Italiano de Buenos AiresRecruitingOveractive Bladder SyndromeArgentina
-
Centre Hospitalier de RoubaixNot yet recruitingIdiopathic Overactive Bladder
-
Pacific Edge LimitedRecruitingUrothelial Bladder CancerUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Institut Paoli-CalmettesNot yet recruitingNon-muscle-invasive Bladder Cancer
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Maastricht University Medical CenterUniversity Hospital, Antwerp; Zuyderland HospitalUnknownOveractive Bladder | Overactive Bladder SyndromeNetherlands
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUrothelial Carcinoma of the BladderUnited States
-
University of Sao Paulo General HospitalCompletedOveractive Bladder SyndromeBrazil
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
University of Sao Paulo General HospitalCompletedOveractive Bladder SyndromeBrazil
-
Federal University of São PauloUnknown
-
Maastricht University Medical CenterUnknownOveractive Bladder SyndromeNetherlands
-
Kissei Pharmaceutical Co., Ltd.Completed
-
University of California, IrvineRecruitingMuscle-Invasive Bladder Cancer | Urothelial Bladder CancerUnited States
-
Istanbul Medeniyet UniversityRecruitingBladder Cancer Recurrent | Non-Invasive Bladder Urothelial CarcinomaTurkey
-
Wake Forest University Health SciencesNot yet recruiting
-
University of SouthamptonNational Institute for Health Research, United KingdomCompleted
-
Leap Therapeutics, Inc.AvailableGastric Cancer | Ovarian Cancer | Gastric Adenocarcinoma | Carcinosarcoma | Endometrial Cancer | Adenocarcinoma of the Gastroesophageal Junction | GastroEsophageal Cancer | Uterine Cancer | Esophageal Neoplasm | Squamous Cell CarcinomaUnited States
-
Ferring PharmaceuticalsFKD Therapies Oy; Society of Urologic Oncology Clinical Trials ConsortiumCompletedSuperficial Bladder CancerUnited States
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenUniversity of AarhusRecruitingNon-Muscle Invasive Bladder CancerDenmark
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Shenzhen Geno-Immune Medical InstituteUnknown
-
Paolo PuppoCompletedNon Muscle Invasive Bladder CancerItaly
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Radboud University Medical CenterWithdrawn